Although drugs known as glucocorticoids are used clinically to treat mothers at risk of preterm delivery and infants with life-threatening lung conditions, there are ongoing concerns about the therapy because it adversely affects brain development. New mouse research suggests that some glucocorticoids, e.g. corticosterone and prednisolone, might be less damaging to the fetal brain than others, such as dexamethasone.